vs
CRYO CELL INTERNATIONAL INC（CCEL）与VIEMED HEALTHCARE, INC.（VMD）财务数据对比。点击上方公司名可切换其他公司
VIEMED HEALTHCARE, INC.的季度营收约是CRYO CELL INTERNATIONAL INC的9.7倍（$76.2M vs $7.8M）。VIEMED HEALTHCARE, INC.净利率更高（7.4% vs -48.7%，领先56.1%）。VIEMED HEALTHCARE, INC.同比增速更快（25.5% vs -2.3%）。VIEMED HEALTHCARE, INC.自由现金流更多（$9.7M vs $1.2M）。过去两年VIEMED HEALTHCARE, INC.的营收复合增速更高（22.7% vs -0.1%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
Viemed Healthcare是一家专注于呼吸护理解决方案的医疗科技企业，研发、生产及销售便携式呼吸机、呼吸治疗设备及配套支持服务，覆盖北美、欧洲及亚太核心市场的急症、亚急症及居家护理场景，服务急慢性呼吸系统疾病患者。
CCEL vs VMD — 直观对比
营收规模更大
VMD
是对方的9.7倍
$7.8M
营收增速更快
VMD
高出27.8%
-2.3%
净利率更高
VMD
高出56.1%
-48.7%
自由现金流更多
VMD
多$8.5M
$1.2M
两年增速更快
VMD
近两年复合增速
-0.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $76.2M |
| 净利润 | $-3.8M | $5.6M |
| 毛利率 | 77.9% | 57.9% |
| 营业利润率 | -50.6% | 11.0% |
| 净利率 | -48.7% | 7.4% |
| 营收同比 | -2.3% | 25.5% |
| 净利润同比 | -105.1% | 30.7% |
| 每股收益（稀释后） | $-0.46 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELVMD
| Q4 25 | $7.8M | $76.2M | ||
| Q3 25 | $7.8M | $71.9M | ||
| Q2 25 | $7.9M | $63.1M | ||
| Q1 25 | $8.0M | $59.1M | ||
| Q4 24 | $8.0M | $60.7M | ||
| Q3 24 | $8.1M | $58.0M | ||
| Q2 24 | $8.0M | $55.0M | ||
| Q1 24 | $7.9M | $50.6M |
净利润CCELVMD
| Q4 25 | $-3.8M | $5.6M | ||
| Q3 25 | $749.4K | $3.5M | ||
| Q2 25 | $355.8K | $3.2M | ||
| Q1 25 | $282.9K | $2.6M | ||
| Q4 24 | $-1.9M | $4.3M | ||
| Q3 24 | $1.1M | $3.9M | ||
| Q2 24 | $655.8K | $1.5M | ||
| Q1 24 | $556.2K | $1.6M |
毛利率CCELVMD
| Q4 25 | 77.9% | 57.9% | ||
| Q3 25 | 77.0% | 57.5% | ||
| Q2 25 | 76.6% | 58.3% | ||
| Q1 25 | 75.1% | 56.3% | ||
| Q4 24 | 78.4% | 59.5% | ||
| Q3 24 | 73.6% | 59.3% | ||
| Q2 24 | 74.8% | 59.8% | ||
| Q1 24 | 73.7% | 58.9% |
营业利润率CCELVMD
| Q4 25 | -50.6% | 11.0% | ||
| Q3 25 | 24.3% | 7.8% | ||
| Q2 25 | 18.8% | 8.1% | ||
| Q1 25 | 13.3% | 6.5% | ||
| Q4 24 | -1.5% | 10.6% | ||
| Q3 24 | 17.2% | 9.7% | ||
| Q2 24 | 17.3% | 6.6% | ||
| Q1 24 | 10.5% | 4.4% |
净利率CCELVMD
| Q4 25 | -48.7% | 7.4% | ||
| Q3 25 | 9.6% | 4.9% | ||
| Q2 25 | 4.5% | 5.0% | ||
| Q1 25 | 3.5% | 4.4% | ||
| Q4 24 | -23.2% | 7.1% | ||
| Q3 24 | 13.0% | 6.7% | ||
| Q2 24 | 8.2% | 2.7% | ||
| Q1 24 | 7.1% | 3.2% |
每股收益（稀释后）CCELVMD
| Q4 25 | $-0.46 | $0.14 | ||
| Q3 25 | $0.09 | $0.09 | ||
| Q2 25 | $0.04 | $0.08 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.23 | $0.10 | ||
| Q3 24 | $0.13 | $0.10 | ||
| Q2 24 | $0.08 | $0.04 | ||
| Q1 24 | $0.07 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $13.5M |
| 总债务越低越好 | $8.4M | — |
| 股东权益账面价值 | $-18.6M | $141.5M |
| 总资产 | $61.7M | $199.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCELVMD
| Q4 25 | $3.3M | $13.5M | ||
| Q3 25 | $3.2M | $11.1M | ||
| Q2 25 | $4.4M | $20.0M | ||
| Q1 25 | $3.5M | $10.2M | ||
| Q4 24 | $3.5M | $17.5M | ||
| Q3 24 | $2.1M | $11.3M | ||
| Q2 24 | $1.5M | $8.8M | ||
| Q1 24 | $979.6K | $7.3M |
总债务CCELVMD
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELVMD
| Q4 25 | $-18.6M | $141.5M | ||
| Q3 25 | $-14.8M | $133.6M | ||
| Q2 25 | $-15.6M | $139.7M | ||
| Q1 25 | $-14.7M | $134.8M | ||
| Q4 24 | $-13.2M | $131.4M | ||
| Q3 24 | $-9.6M | $125.0M | ||
| Q2 24 | $-10.7M | $119.4M | ||
| Q1 24 | $-10.3M | $116.3M |
总资产CCELVMD
| Q4 25 | $61.7M | $199.2M | ||
| Q3 25 | $63.2M | $202.4M | ||
| Q2 25 | $64.4M | $184.6M | ||
| Q1 25 | $64.4M | $178.1M | ||
| Q4 24 | $64.7M | $177.1M | ||
| Q3 24 | $62.9M | $169.5M | ||
| Q2 24 | $62.6M | $163.9M | ||
| Q1 24 | $61.7M | $154.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $18.4M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $9.7M |
| 自由现金流率自由现金流/营收 | 15.5% | 12.7% |
| 资本支出强度资本支出/营收 | 0.9% | 11.5% |
| 现金转化率经营现金流/净利润 | — | 3.27× |
| 过去12个月自由现金流最近4个季度 | $5.2M | $11.9M |
8季度趋势，按日历期对齐
经营现金流CCELVMD
| Q4 25 | $1.3M | $18.4M | ||
| Q3 25 | $2.5M | $18.4M | ||
| Q2 25 | $707.0K | $12.3M | ||
| Q1 25 | $954.1K | $2.9M | ||
| Q4 24 | $2.2M | $15.0M | ||
| Q3 24 | $2.4M | $12.7M | ||
| Q2 24 | $1.8M | $10.2M | ||
| Q1 24 | $-356.9K | $1.2M |
自由现金流CCELVMD
| Q4 25 | $1.2M | $9.7M | ||
| Q3 25 | $2.5M | $10.7M | ||
| Q2 25 | $644.6K | $4.1M | ||
| Q1 25 | $892.0K | $-12.6M | ||
| Q4 24 | $2.1M | $3.2M | ||
| Q3 24 | $2.3M | $1.7M | ||
| Q2 24 | $21.5K | $1.2M | ||
| Q1 24 | $-814.6K | $-4.8M |
自由现金流率CCELVMD
| Q4 25 | 15.5% | 12.7% | ||
| Q3 25 | 31.9% | 14.9% | ||
| Q2 25 | 8.1% | 6.5% | ||
| Q1 25 | 11.2% | -21.4% | ||
| Q4 24 | 26.8% | 5.2% | ||
| Q3 24 | 27.9% | 3.0% | ||
| Q2 24 | 0.3% | 2.3% | ||
| Q1 24 | -10.4% | -9.5% |
资本支出强度CCELVMD
| Q4 25 | 0.9% | 11.5% | ||
| Q3 25 | 0.5% | 10.6% | ||
| Q2 25 | 0.8% | 12.9% | ||
| Q1 25 | 0.8% | 26.2% | ||
| Q4 24 | 0.1% | 19.5% | ||
| Q3 24 | 2.3% | 19.0% | ||
| Q2 24 | 21.8% | 16.3% | ||
| Q1 24 | 5.8% | 11.9% |
现金转化率CCELVMD
| Q4 25 | — | 3.27× | ||
| Q3 25 | 3.38× | 5.23× | ||
| Q2 25 | 1.99× | 3.88× | ||
| Q1 25 | 3.37× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 2.32× | 3.29× | ||
| Q2 24 | 2.70× | 6.94× | ||
| Q1 24 | -0.64× | 0.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
